Perception of body mass index and health issues related to overweight/obesity in an outpatient women’s clinic

Cook, J. W.; Caudell, Chloe W.; Cai, Bo; Lane‐Cordova, Abbi D.; Lenard, Matthew; Beste, Mary; Montaguefarwell, Elizabeth

doi:10.1080/03630242.2020.1831684

Cited by 3 publications

(11 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…14,15 These prior studies demonstrated that 30-42% of individuals were aware of the association between obesity and the increased risk of endometrial cancer, 14,15 which is similar to our findings that approximately 30% of individuals in our population were aware of the association between obesity and PFDs. These findings add to the growing evidence that suggests there is a lack of knowledge of the association between obesity and the risk of women's health and gynecologic issues 17 such as gynecologic cancers, 14,15 infertility and preconception issues, 18,19 and PFDs. In comparison, studies demonstrate much higher awareness of the association between obesity and the risk of other health issues, such as hypertension and diabetes, among both male and female participants.…”

Section: Discussionmentioning

confidence: 54%

Public Awareness of Obesity and Risk of Pelvic Floor Disorders: A Cohort Study

Husk¹,

Leong²,

Rogers³

et al. 2023

UROGC

View full text Add to dashboard Cite

Importance Obesity is a risk factor for pelvic floor disorders (PFDs), but limited information exists about the public awareness of this association. Objective Our primary objective was to assess awareness of the association between obesity and PFDs, comparing 2 cohorts of women with body mass index (BMI) <30 versus BMI ≥30. Study Design We conducted a cross-sectional, survey-based cohort study. The survey included questions about demographics, height and weight selfassessment, and the risk of PFDs with obesity. Our primary outcome was the rate of women correctly identifying that obesity increases the risk of PFDs. Results Of 377 eligible participants 272 (72.1%) completed the survey, with 266 analyzed. Of these, 159 (59.8%) had a BMI <30 and 107 (40.2%) had a BMI ≥30. Comparing the cohorts, the lower BMI cohort was older (mean age of 54.4 ± 18.3 vs 48.4 ± 17.5 years, P = 0.008) and had higher rates of graduate/professional school (35.2% vs 19.6%, P = 0.04). Both groups had similarly high rates of PFDs. There was no difference in identifying obesity as a risk factor for PFDs, although the lower BMI group was less likely to identify the implications of weight loss on urinary incontinence (UI) (27.7% vs 45.8%, P = 0.002). Controlling for potential confounders, obesity remained positively associated with knowledge about the implications of weight loss on UI (odds ratio, 2.5; 95% confidence interval, 1.5-4.4). Conclusions Few women identified the increased risk of PFDs with obesity. Obese women may have increased awareness of the implications of weight loss on UI.

show abstract

Section: Discussionmentioning

confidence: 54%

Public Awareness of Obesity and Risk of Pelvic Floor Disorders: A Cohort Study

Husk¹,

Leong²,

Rogers³

et al. 2023

UROGC

View full text Add to dashboard Cite

show abstract

“…Р озвиток жіночого організму від народження до репродуктивного розквіту та згасання фертильної функції прийнято розділяти на окремі періоди, які характеризуються певними морфологічними та функціональними особливостями. У реаліях сьогодення, враховуючи багатофакторність патогенезу порушень жіночого здоров'я, саме ефективні стратегії та методи його збереження повинні бути мультитаргетними та патогенетично обґрунтованими задля корекції функціональних розладів як вищих регуляторних структур, так і кінцевих ефекторних клітинних відповідей [1][2][3].…”

Section: н а д о п о м о г у л і к а р ю -п р а к т и к уunclassified

“…Визначено, що при аліментарному ожирінні у 6 разів частіше діагностують порушення менструальної функції та майже у 2 рази частішепервинне безпліддя. Існує пряма залежність між збільшенням маси тіла та вираженістю оваріальної дисфункції, що проявляється ановуляцією, недостатністю другої фази менструального циклу та зменшенням кількості вагітностей [3][4][5].…”

Section: метаболічний синдром і його вплив на здоров'я жінкиunclassified

Modern opportunities and prospects for preserving woman’s health

Kondratiuk

Gasparyan

et al. 2022

RHW

View full text Add to dashboard Cite

Among the variety of factors that affect the female organism, obesity is of great importance in the formation, development and functioning of the reproductive system, the development of gynecological diseases in which metabolic syndrome plays an important pathogenetic role (polycystic ovary syndrome is diagnosed in 35-60% of obese women; menstrual dysfunction – in 6 times more often, primary infertility – 2 times more). The components of the metabolic syndrome have a significant effect on the body: insulin resistance, hyperinsulinemia, dyslipoproteinemia, elevated levels of thrombosis factors. This article reviews the current scientific literature on the role of sirtuins in the regulatory cellular processes and metabolic cascades, with special emphasis on the possibilities of their pharmacological activation by resveratrol. The role of resveratrol as a promoter of sirtuin activity at different levels of homeostasis disturbance was analyzed, and the properties of resveratrol, its effects and impact on the female body in the presence of metabolic pathology were analyzed in order to prescribe timely treatment and slow down the reproductive aging process.Literature data prove the importance of polyphenols (resveratrol) use as an effective and pathogenetically determined activator of sirtuins for the regulation of oxidative stress, inflammation, correction of dysbiosis and imbalance of the immune system in the concept of treatment of women with gynecological diseases and metabolic disorders. Resveratrol itself has a wide range of pharmacological effects with proven antilipogenic properties and a safe harmonizing estrogen-like effect on various regulatory levels. The natural plant composition and long history of use of resveratrol have repeatedly revealed its clinical achievements, including polycystic ovary syndrome treatment. The high clinical effectiveness and safety profile allow to recommend the inclusion of resveratrol in treatment regimens and to prevent the relapses of metabolically determined gynecological and somatic diseases in women of various age periods.

show abstract

“…18 In addition, perceived body weight may predict body weight shame. 19 However, there is conflicting information about whether women perceive their BMI accurately, 20,21 underestimate their BMI or body weight category [22][23][24][25] or perceive their body image as heavier than desired. 23,26 Most women may be unaware that high BMI may contribute to poor health outcomes and early death.…”

Section: Introductionmentioning

confidence: 99%

“…23,26 Most women may be unaware that high BMI may contribute to poor health outcomes and early death. 20,22 Communication between providers and patients who have a BMI > 25 kg/m 2 may be improved with methods such as motivational interviewing, but provider experience with these methods may be limited. 13,27,28 In addition, providers may lack knowledge about optimal language use or guidelines about how to facilitate discussions and provide support about obesity.…”

Section: Introductionmentioning

confidence: 99%

Women's perceptions of body mass graphics and their preferences for weight counselling

Kaak,

Holliday,

Mulekar

et al. 2023

Clinical Obesity

View full text Add to dashboard Cite

SummaryHealth care providers may lack data‐driven guidance about best practises for discussing weight. We assessed women's self‐perception of body mass index (BMI) and preferences for weight counselling by provider characteristics and the initiating question. A voluntary, anonymous survey was completed by 756 women (age ≥ 19 year) at our tertiary care obstetrics and gynaecology clinics in autumn 2021. The respondents' height and weight were collected before respondents selected graphics from a validated Body Image Scale that they felt best represented their current body size and which graphs should prompt weight loss or gain recommendations. Respondents were asked their preferences about provider characteristics for discussion about weight and to identify which of six initiating questions from a provider was most and least preferred. Blank responses were allowed. In 708 responses, 366 women (52%) selected the most accurate graphic that corresponded to their BMI; the selected graphic represented a lower than actual BMI in 268 women (38%) and higher in 74 women (10%). In 648 responses, 374 women (58%) preferred a female provider, but provider body shape, ethnicity/race and age were not important to most women. The most preferred question to initiate a discussion about weight was “A lot of women have trouble achieving or maintaining a healthy weight; is that something we can discuss?” in 181 of 555 women (33%), and the least preferred question was “Do you feel like you are at an appropriate weight?” in 172 of 554 women (31%). Provider knowledge about patient preferences regarding questions may facilitate the discussion about weight.

show abstract

Perception of body mass index and health issues related to overweight/obesity in an outpatient women’s clinic

Cited by 3 publications

References 13 publications

Public Awareness of Obesity and Risk of Pelvic Floor Disorders: A Cohort Study

Public Awareness of Obesity and Risk of Pelvic Floor Disorders: A Cohort Study

Modern opportunities and prospects for preserving woman’s health

Women's perceptions of body mass graphics and their preferences for weight counselling

Contact Info

Product

Resources

About